Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × ruxolitinib × 30 days × Clear all

Sponsor

Conditions

Primary Myelofibrosis 5 Thrombocythemia, Essential 3 Myeloproliferative Disorders 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Polycythemia Vera 2 Myelodysplastic-Myeloproliferative Diseases 2 Myelodysplastic Syndromes 2 Leukemia 2 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma 1 Leukemia, Monocytic, Acute 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Graft vs Host Disease 1 Glioma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Bronchiolitis Obliterans Syndrome 1

Interventions

fludarabine 2 Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 Biopsy 2 treosulfan 1 talimogene laherparepvec 1 sodium-iodide symporter 1 relatlimab 1 entrectinib 1 cemiplimab 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Stem Cell Transplantation 1 Photons 1 Mycophenolic Acid 1 Ipilimumab 1 Immunoglobulin G 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Disulfides 1 Cyclosporins 1 Cyclosporine 1 CTLA-4 Antigen 1 Azacitidine 1 Abatacept 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡